CD105 Antibody for Targeting of Tumor Vascular Endothelial Cells
- 1 January 2002
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994
- Angiogenesis inhibition: A reviewPharmacology & Therapeutics, 1994
- Identification and expression of two forms of the human transforming growth factor‐β‐binding protein endoglin with distinct cytoplasmic regionsEuropean Journal of Immunology, 1993
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Antibody Conjugates for the Treatment of CancerImmunological Reviews, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Regulated expression on human macrophages of endoglin, an Arg‐Gly‐Asp‐containing surface antigenEuropean Journal of Immunology, 1992
- Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agentsBioEssays, 1991